Everyone gets stuck at some point. The difference is in how quickly you resolve the situation and carry on.

The multinational pharmaceutical giant Bayer Korea was certainly ‘stuck’ at one point. Although the company had released and successfully sold liver cancer treatments ‘Nexavar’ and ‘Stivarga,’ the anticoagulant ‘Xarelto,’ and the wet age-related macular degeneration treatment ‘Eylea,’ no news of the next 'big thing' had risen for a while. Also, some of the company’s new drugs were approved but had difficulty receiving reimbursement.

But Bayer pushed through and has carried on. In the past 6 months, the company has launched the heart failure drug Verquovo and chronic kid